The global Interventional Neurology Devices Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Cerebral Balloon Angioplasty and Stenting Systems, Neurothrombectomy Devices, Aneurysm Coiling and Embolization Devices, Micro-catheters, Guidewires), By Application (Artery Stenosis, Ischemic Strokes, Brain Aneurysm, Vein Stenosis, Others).
The Interventional Neurology Devices Market includes medical devices and technologies used in neurovascular interventions for treating conditions such as stroke, aneurysms, arteriovenous malformations (AVMs), and neurovascular diseases. This market comprises neurothrombectomy devices, embolization coils, stent retrievers, flow diverters, neurovascular catheters, and intracranial stents used in endovascular procedures. Innovations in interventional neurology devices focus on thrombectomy techniques, neuroimaging technologies, neuroprotection strategies, and personalized treatment approaches, improving outcomes and quality of life for patients with neurovascular disorders.
The global Interventional Neurology Devices Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Interventional Neurology Devices Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Interventional Neurology Devices Industry include- Abbott Laboratories, B. Braun SE, Boston Scientific Corp, Canon Inc, Integer Holdings Corp, Johnson & Johnson, Medtronic Plc, Merit Medical Systems., MicroPort Scientific Corp, Penumbra Inc, Stryker Corp, Terumo Corp.
A significant trend in the market for interventional neurology devices is the expansion of mechanical thrombectomy for acute stroke intervention. Mechanical thrombectomy involves the use of specialized devices such as stent retrievers and aspiration catheters to remove blood clots from blocked arteries in the brain, improving blood flow and reducing the risk of disability and mortality in stroke patients. This trend is driven by growing evidence supporting the effectiveness of mechanical thrombectomy, advancements in device technology, and efforts to improve access to timely stroke treatment, leading to increased adoption of interventional neurology devices in acute stroke care.
The primary driver of the interventional neurology devices market is the aging population and the associated increase in the burden of neurological disorders such as stroke, cerebral aneurysms, and intracranial hemorrhage. As the global population ages and the prevalence of stroke risk factors such as hypertension and diabetes rises, there is a growing demand for innovative devices and techniques to diagnose and treat neurological conditions. This driver underscores the importance of interventional neurology devices in improving patient outcomes, reducing disability, and addressing the unmet medical needs of neurology patients.
An opportunity in the interventional neurology devices market lies in the development of novel embolization devices and stroke imaging technologies. Embolization devices such as flow diverters, detachable coils, and liquid embolics offer minimally invasive options for treating cerebral aneurysms, arteriovenous malformations (AVMs), and other vascular lesions in the brain. Additionally, advancements in stroke imaging modalities such as perfusion imaging, CT angiography, and MRI can aid in patient selection, treatment planning, and post-procedural monitoring, enhancing the effectiveness and safety of interventional neurology procedures.
Among the various products in interventional neurology devices, Neurothrombectomy Devices are experiencing the fastest growth. Neurothrombectomy devices are specifically designed to remove blood clots from cerebral arteries in patients experiencing acute ischemic strokes, a leading cause of disability and mortality worldwide. These devices enable rapid and effective clot removal, restoring blood flow to the affected area of the brain and reducing the risk of permanent neurological damage. The increasing recognition of the importance of timely intervention in acute ischemic strokes has driven the demand for neurothrombectomy devices. Additionally, advancements in device design and technology, such as stent retrievers and aspiration catheters, have improved the efficacy and safety of neurothrombectomy procedures, further fueling their adoption by healthcare providers. As stroke management protocols continue to emphasize the importance of endovascular therapies, including neurothrombectomy, in improving patient outcomes, the market for neurothrombectomy devices is expected to see sustained rapid growth, addressing an unmet need in the treatment of acute ischemic strokes.
By Product
Cerebral Balloon Angioplasty and Stenting Systems
-Carotid Artery Stents
-Embolic Protection Systems
Neurothrombectomy Devices
Aneurysm Coiling and Embolization Devices
Micro-catheters
Guidewires
By Application
Artery Stenosis
Ischemic Strokes
Brain Aneurysm
Vein Stenosis
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott Laboratories
B. Braun SE
Boston Scientific Corp
Canon Inc
Integer Holdings Corp
Johnson & Johnson
Medtronic Plc
Merit Medical Systems.
MicroPort Scientific Corp
Penumbra Inc
Stryker Corp
Terumo Corp
* List not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Interventional Neurology Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Interventional Neurology Devices Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Interventional Neurology Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Interventional Neurology Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Interventional Neurology Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Interventional Neurology Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Interventional Neurology Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Interventional Neurology Devices Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Interventional Neurology Devices Industry
4.2 Key Market Trends in Interventional Neurology Devices Industry
4.3 Potential Opportunities in Interventional Neurology Devices Industry
4.4 Key Challenges in Interventional Neurology Devices Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Interventional Neurology Devices Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Interventional Neurology Devices Market Outlook by Segments
7.1 Interventional Neurology Devices Market Outlook by Segments, $ Million, 2021- 2030
By Product
Cerebral Balloon Angioplasty and Stenting Systems
-Carotid Artery Stents
-Embolic Protection Systems
Neurothrombectomy Devices
Aneurysm Coiling and Embolization Devices
Micro-catheters
Guidewires
By Application
Artery Stenosis
Ischemic Strokes
Brain Aneurysm
Vein Stenosis
Others
8 North America Interventional Neurology Devices Market Analysis and Outlook To 2030
8.1 Introduction to North America Interventional Neurology Devices Markets in 2024
8.2 North America Interventional Neurology Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Interventional Neurology Devices Market size Outlook by Segments, 2021-2030
By Product
Cerebral Balloon Angioplasty and Stenting Systems
-Carotid Artery Stents
-Embolic Protection Systems
Neurothrombectomy Devices
Aneurysm Coiling and Embolization Devices
Micro-catheters
Guidewires
By Application
Artery Stenosis
Ischemic Strokes
Brain Aneurysm
Vein Stenosis
Others
9 Europe Interventional Neurology Devices Market Analysis and Outlook To 2030
9.1 Introduction to Europe Interventional Neurology Devices Markets in 2024
9.2 Europe Interventional Neurology Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Interventional Neurology Devices Market Size Outlook by Segments, 2021-2030
By Product
Cerebral Balloon Angioplasty and Stenting Systems
-Carotid Artery Stents
-Embolic Protection Systems
Neurothrombectomy Devices
Aneurysm Coiling and Embolization Devices
Micro-catheters
Guidewires
By Application
Artery Stenosis
Ischemic Strokes
Brain Aneurysm
Vein Stenosis
Others
10 Asia Pacific Interventional Neurology Devices Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Interventional Neurology Devices Markets in 2024
10.2 Asia Pacific Interventional Neurology Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Interventional Neurology Devices Market size Outlook by Segments, 2021-2030
By Product
Cerebral Balloon Angioplasty and Stenting Systems
-Carotid Artery Stents
-Embolic Protection Systems
Neurothrombectomy Devices
Aneurysm Coiling and Embolization Devices
Micro-catheters
Guidewires
By Application
Artery Stenosis
Ischemic Strokes
Brain Aneurysm
Vein Stenosis
Others
11 South America Interventional Neurology Devices Market Analysis and Outlook To 2030
11.1 Introduction to South America Interventional Neurology Devices Markets in 2024
11.2 South America Interventional Neurology Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Interventional Neurology Devices Market size Outlook by Segments, 2021-2030
By Product
Cerebral Balloon Angioplasty and Stenting Systems
-Carotid Artery Stents
-Embolic Protection Systems
Neurothrombectomy Devices
Aneurysm Coiling and Embolization Devices
Micro-catheters
Guidewires
By Application
Artery Stenosis
Ischemic Strokes
Brain Aneurysm
Vein Stenosis
Others
12 Middle East and Africa Interventional Neurology Devices Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Interventional Neurology Devices Markets in 2024
12.2 Middle East and Africa Interventional Neurology Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Interventional Neurology Devices Market size Outlook by Segments, 2021-2030
By Product
Cerebral Balloon Angioplasty and Stenting Systems
-Carotid Artery Stents
-Embolic Protection Systems
Neurothrombectomy Devices
Aneurysm Coiling and Embolization Devices
Micro-catheters
Guidewires
By Application
Artery Stenosis
Ischemic Strokes
Brain Aneurysm
Vein Stenosis
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
B. Braun SE
Boston Scientific Corp
Canon Inc
Integer Holdings Corp
Johnson & Johnson
Medtronic Plc
Merit Medical Systems.
MicroPort Scientific Corp
Penumbra Inc
Stryker Corp
Terumo Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Cerebral Balloon Angioplasty and Stenting Systems
-Carotid Artery Stents
-Embolic Protection Systems
Neurothrombectomy Devices
Aneurysm Coiling and Embolization Devices
Micro-catheters
Guidewires
By Application
Artery Stenosis
Ischemic Strokes
Brain Aneurysm
Vein Stenosis
Others
The global Interventional Neurology Devices Market is one of the lucrative growth markets, poised to register a 8.3% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott Laboratories, B. Braun SE, Boston Scientific Corp, Canon Inc, Integer Holdings Corp, Johnson & Johnson, Medtronic Plc, Merit Medical Systems., MicroPort Scientific Corp, Penumbra Inc, Stryker Corp, Terumo Corp
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume